Production (Stage)
Citius Pharmaceuticals, Inc.
CTXR
$0.703
-$0.021-2.90%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -99.79% | -94.59% | -87.72% | -46.18% | -56.79% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -66.62% | -63.82% | -65.78% | 28.88% | 54.47% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -14.83% | -35.03% | -58.63% | -31.88% | -38.19% |
|
|
|||||
| Total Current Assets | -14.83% | -35.03% | -58.63% | -31.88% | -38.19% |
| Net Property, Plant & Equipment | 161.37% | -52.73% | -46.00% | -40.71% | -36.41% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | 56.23% | 56.23% | 56.23% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Assets | 33.92% | 23.93% | 12.59% | -12.06% | -12.98% |
|
|
|||||
| Total Accounts Payable | 250.93% | 178.17% | 1,038.50% | -45.99% | -2.06% |
| Total Accrued Expenses | 838.81% | 226.39% | -14.71% | -9.81% | -61.11% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -36.83% | -8.66% | 10.58% | 10.66% | 10.70% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1,095.08% | 703.15% | 519.74% | -28.30% | -32.79% |
|
|
|||||
| Total Current Liabilities | 1,095.08% | 703.15% | 519.74% | -28.30% | -32.79% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 442.18% | -- | -91.90% | -73.63% | -61.29% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 12.71% | 11.08% | 9.38% | 9.61% | 9.85% |
| Total Liabilities | 438.94% | 329.20% | 249.35% | -10.73% | -13.59% |
|
|
|||||
| Common Stock & APIC | 9.00% | 7.94% | 7.27% | 10.51% | 10.36% |
| Retained Earnings | -23.36% | -23.14% | -24.13% | -25.14% | -25.17% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -23.57% | -22.81% | -22.85% | -12.30% | -12.98% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -23.57% | -22.81% | -22.85% | -12.30% | -12.98% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 385.74% | 484.84% | 570.29% | 0.00% | 0.00% |
| Total Equity | -20.50% | -19.24% | -18.95% | -12.22% | -12.90% |
|
|
|||||